Sun Pharmaceutical Industries
SUNPHARMANSE

Sun Pharmaceutical Industries

₹1,693.60-34.90 (2.02%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O
Livesquawk
HC restricts Intas from selling a drug similar to Sun Pharma's Bevetyx. This bolsters Sun Pharma's intellectual property in the oncology market.
Livesquawk
Sun Pharma reported an NSE block trade of 139,124 shares at Rs. 1,800 each. The total trade value amounted to approximately Rs. 25.04 crore.